MedPath
Found 13 clinical trials|View Analysis
Sort by:

A Study of Different Forms of BGB-43395 and Food Effect in Healthy Participants

Phase 1
Not yet recruiting
Conditions
Healthy Volunteers
Interventions
Drug: BGB-43395
First Posted Date
2025-01-07
Last Posted Date
2025-01-07
Lead Sponsor
BeiGene
Target Recruit Count
48
Registration Number
NCT06761898

Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Drug: Tolebrutinib
Drug: Placebo
First Posted Date
2023-10-30
Last Posted Date
2023-10-30
Lead Sponsor
Sanofi
Target Recruit Count
71
Registration Number
NCT06106074
Locations
🇺🇸

New Orleans Clinical Research Site Number : 8400001, Knoxville, Tennessee, United States

Effect of Food on the Pharmacokinetics of ORIC-114

Phase 1
Completed
Conditions
Food Effect in Healthy Participants
Interventions
Drug: ORIC-114
First Posted Date
2023-08-25
Last Posted Date
2024-01-19
Lead Sponsor
ORIC Pharmaceuticals
Target Recruit Count
32
Registration Number
NCT06012721
Locations
🇦🇺

Nucleus Network Pty Ltd., 235 Ryrie St, Geelong, Victoria, Australia

🇦🇺

Nucleus Network Pty Ltd., Level 5, Burnet Tower, 89 Commercial Rd, Melbourne, Victoria, Australia

Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD

Phase 1
Completed
Conditions
Lower Respiratory Disease
Pulmonary Disease
Healthy
Respiratory Disease
COPD
Interventions
Drug: Vapendavir
First Posted Date
2023-07-27
Last Posted Date
2024-07-30
Lead Sponsor
Altesa Biosciences, Inc.
Target Recruit Count
21
Registration Number
NCT05962645
Locations
🇺🇸

Syneos Health Miami, Miami, Florida, United States

A Food Effect Study of JAB-21822 in Healthy Subjects

Phase 1
Completed
Conditions
Food Effect in Healthy Participants
Interventions
First Posted Date
2023-05-25
Last Posted Date
2024-01-05
Lead Sponsor
Jacobio Pharmaceuticals Co., Ltd.
Target Recruit Count
18
Registration Number
NCT05875493
Locations
🇨🇳

Beijing GoBroad Boren Hospital, Beijing, Beijing, China

Maribavir Food-Effect Study in Healthy Adults Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2022-05-19
Last Posted Date
2024-02-16
Lead Sponsor
Takeda
Target Recruit Count
31
Registration Number
NCT05382104
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: BMS-986177 Oral Solution
Drug: [14C]BMS-986177 Solution for Infusion
Drug: BMS-986177 Spray-dried Dispersion Capsules
First Posted Date
2021-07-16
Last Posted Date
2023-08-21
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
17
Registration Number
NCT04965389
Locations
🇬🇧

Local Institution, Nottingham, United Kingdom

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants

Phase 1
Completed
Conditions
Autistic Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders
Autism Spectrum Disorder
Interventions
First Posted Date
2020-07-17
Last Posted Date
2024-07-10
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
88
Registration Number
NCT04475848
Locations
🇬🇧

Hammersmith Medicines Research; Central Middlesex Hospital, London, United Kingdom

A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: TLL018 tablet, placebo
First Posted Date
2020-01-28
Last Posted Date
2021-03-30
Lead Sponsor
TLL Pharmaceutical, LLC
Target Recruit Count
100
Registration Number
NCT04243083
Locations
🇺🇸

Frontage Clinical Services, Inc., Secaucus, New Jersey, United States

A Food-Effect Study of E7386 in Healthy Participants

Phase 1
Completed
Conditions
Food Effect in Healthy Participants
Interventions
Drug: E7386
First Posted Date
2019-06-24
Last Posted Date
2019-11-14
Lead Sponsor
Eisai Inc.
Target Recruit Count
17
Registration Number
NCT03996226
Locations
🇺🇸

PPD, Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath